ARBUTUS BIOPHARMA CORP NPV earnings per share and revenue

0SGC earnings per share for the last quarter are -0.10 USD whereas the estimation was -0.11 USD which accounts for 9.09% surprise. Företagets omsättning för samma period uppgår till 1.53 M USD trots den uppskattade siffran 2.71 M USD. Estimated earnings per share for the next quarter are -0.10 USD, and revenue is expected to reach 1.77 M USD. Also watch annual changes over time to get a bigger picture of 0SGC earnings per share and revenue dynamics.